Accendra Health Reports Third Quarter 2026 Financial Results
Key Highlights
- ➤Q3 net revenue $601.8 million, down from $697.3 million year over year
- ➤Q3 adjusted EBITDA $47.8 million, down from $92.2 million year over year
- ➤2026 revenue expected at bottom of $2.45 billion-$2.55 billion outlook range
- ➤2026 adjusted EBITDA could be 30% below prior $310 million midpoint
- ➤Q3 continuing-operations loss widened to $18.0 million from $5.6 million
Expert Statements
Kenny Gardner-Smith, President and Chief Executive Officer, Accendra Health
“Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate population dedicated to our mission, Bringing Care To Life. It is equally clear to me that our results to date in 2026 have fallen well short of our expectations and potential. We have identified four key areas which are critical to our continued transformation and returning the business to the kind of profitability that our shareholders should expect,”
Kenny Gardner-Smith, President and Chief Executive Officer, Accendra Health
“We are already taking action on our turnaround, and, over the next several months, we will have our value creation plan fully underway. The value creation plan is the cornerstone of returning the business to its potential, and we look forward to sharing details with all stakeholders in the coming months,”
Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the third quarter ended September 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations.
“Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate population dedicated to our mission, Bringing Care To Life. It is equally clear to me that our results to date in 2026 have fallen well short of our expectations and potential. We have identified four key areas which are critical to our continued transformation and returning the business to the kind of profitability that our shareholders should expect,” said Kenny Gardner-Smith, President & Chief Executive Officer, Accendra Health.
Get started
Create a free account to read the full story.